| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8210997 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 35 Pages |
Abstract
Hypofractionated radiation therapy appears to be well tolerated and effective in men aged ⥠75 years. The 57-Gy schedule has potential advantages in that it may moderate long-term side effects without compromising treatment efficacy in this group.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
James M. FRCR, David P. FRCR, Isabel MD, Vincent MD, Alison FRCR, David FRCR, Ananya FRCR, John FRCR, Catherine FRCR, Zafar FRCR, Julian FRCR, Joe M. FRCR, Miguel FRCR, Chris FRCR, Yvonne FRCR, Christopher FRCR, John MD, Andrew FRCR, Emma PhD,